CHOSOURCE advances biotherapeutic production

A three-part customer presentation series 
See how the CHOSOURCE expression platform is currently being used to advance commercial biotherapeutic production pipelines.
This three-part customer presentation series features Dr Allyn Spear of Elanco Animal Health, Michael Cullivan of Jounce Therapeutics and Dr Jeffrey McGrew of Just-Evotech Biologics as they share how their teams have used Horizon's CHOSOURCE to improve their biomanufacturing workflows.

Cell lines for optimizing biotherapeutic production workflows

Dr Allyn Spear discusses Elanco Animal Health’s experience implementing the CHOSOURCE GS knockout cell line for building a biotherapeutics research program in animal health.

Contact us to discuss your project


Required fields marked with * Required

Are you stable or transient? Optimize your biotherapeutic workflow

Jounce Therapeutics have successfully integrated the CHOSOURCE platform to build efficiencies across their drug development workflow. Michael Cullivan highlights the benefits of transient and stable transfections of CHO cell lines for various production purposes using their own experiences.

Optimizing Biotherapeutic Cell Lines for Continuous Manufacturing

Learn from Jeffrey McGrew, PhD, Scientific Director at Just-Evotech Biologics on how the CHOSOURCE line has enabled them to implement intensified low-cost manufacturing processes in their bioprocessing workflow.